Back
American Express Co. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
69
AXP
American Express Co.
Last Price:
$375.56
Seasonality Move:
3.6%
Sell
36
MNPR
Monopar Therapeutics, Inc.
Last Price:
$68.03
Seasonality Move:
36.18%
Buy
69
American Express Co. (AXP)
is a Buy
Is American Express Co. a Buy, Sell or Hold?
-
The current American Express Co. [AXP] share price is $375.61. The Score for AXP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXP Stock Price Chart
What is American Express Co.'s stock price today?
-
The American Express Co. share price today is $375.61The current trend is moderately bullish and AXP is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $67.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
AXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.76 | Buy |
| Relative Strength Index (14 RSI): | 58.2 | Buy |
| Chaikin Money Flow: | -2330133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (351.58 - 376.78) | Buy |
| Bollinger Bands (100): | (314.43 - 362.97) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.86 | Sell |
| Relative Strength Index (14 RSI): | 33.87 | Sell |
| Chaikin Money Flow: | -124010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.34 - 86.38) | Sell |
| Bollinger Bands (100): | (44.81 - 88.99) | Buy |
AXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 376.02 | Sell |
| 20-day SMA: | 366.4 | Buy |
| 50-day SMA: | 357.11 | Buy |
| 200-day SMA: | 312.11 | Buy |
| 8-day EMA: | 376.41 | Sell |
| 20-day EMA: | 369.65 | Buy |
| 50-day EMA: | 358.17 | Buy |
| 200-day EMA: | 322.86 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.5 | Sell |
| 20-day SMA: | 80.22 | Sell |
| 50-day SMA: | 82.77 | Sell |
| 200-day SMA: | 51.96 | Buy |
| 8-day EMA: | 74.03 | Sell |
| 20-day EMA: | 77.79 | Sell |
| 50-day EMA: | 77.58 | Sell |
| 200-day EMA: | 56.47 | Buy |
American Express Co. Earnings Growth & AXP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $2.01 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
American Express Co. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||